School of Medicine
Showing 301-400 of 536 Results
-
Saisindhu Narala, MD, MAS
Clinical Assistant Professor, Dermatology
Clinical Assistant Professor, PathologyBioDr. Narala completed her dermatology residency at the University of Texas at Houston and MD Anderson Cancer Center. She then completed a fellowship in dermatopathology at Stanford. Her clinical interests include general medical dermatology, dermatology in skin of color, and pigmentary disorders. She also has an interest in medical education.
-
Yasodha Natkunam, M.D., Ph.D
Ronald F. Dorfman, MBBch, FRCPath Professor of Hematopathology
On Leave from 06/01/2025 To 06/30/2025Current Research and Scholarly InterestsMy research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.
-
Roberto Novoa, MD
Clinical Professor, Pathology
Clinical Professor, DermatologyCurrent Research and Scholarly InterestsMy research interests include the medical applications of artificial intelligence, cutaneous lymphoma, and the side effects of targeted therapies. I have served as the lead dermatologist in our ongoing effort to develop AI-augmented classification of skin lesions. We are in the process of establishing one of the first prospective studies examining the performance of a deep learning algorithm in real-world patients.
-
Jean Oak
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsDr. Oak received her MD and PhD from University of California, Irvine, and completed her anatomic pathology and clinical pathology residency, hematopathology fellowship, and transfusion medicine fellowship at Stanford University. Her research and clinical interests include clinical assay development for tumor immunophenotyping, lymphocyte subset monitoring, and immunotherapy target antigen assessment in a variety of hematologic and immunologic disorders. As director of a clinical flow cytometry laboratory, she oversees the design, validation, and implementation of various immunophenotyping assays in addition to ensuring quality assurance and regulatory compliance for CLIA certification.
-
Derick Okwan
Assistant Professor of Pathology
Current Research and Scholarly InterestsBroadly, the Okwan lab’s primary interest is to understand how and why the immune system contributes to nearly all chronic diseases. The immune system of the modern human has evolved from a history of stress to the species: famines, continual bouts of lethal pandemics, as well as major climate/environmental and migratory changes that exposed the immune system to novel threats. At the forefront of these challenges are innate immune cells, particularly neutrophils, the most abundant leukocytes. For the first time in human history – at least in the western world- we live in an era of abundance. The Okwan lab is interested in understanding how this traumatic history creates a functional mismatch for the neutrophil, which we believe underpins their roles in chronic diseases of the modern era: cancer, cardiovascular disease, neurodegeneration, and autoimmune disorders. Rather than wholesale depletion of neutrophils and innate immune cells, we seek to identify novel approaches to leverage these cells to combat various diseases.
-
Michael G. Ozawa
Clinical Associate Professor, Pathology
BioDr. Ozawa is a Clinical Associate Professor of Pathology with subspecialty focus in Cytopathology, Head and Neck pathology, and Thoracic pathology. He completed his M.D., Ph.D. training at the McGovern Medical School and the M. D. Anderson Cancer Center in Houston, TX. He then completed residency training in Anatomic and Clinical Pathology followed by fellowship training in Surgical Pathology and Cytopathology at Stanford University. He is board certified in Anatomic and Clinical Pathology as well as Cytopathology. His interests include pulmonary neoplasms as well as neoplasms of the Head and Neck. He also has developed collaborative research interests in utilizing fine needle aspiration (FNA) techniques in the growing clinical application of Chimeric Antigen T Cell (CAR-T) therapy.
-
Tianyu Pan
Postdoctoral Scholar, Pathology
BioI received my Ph.D. in Statistics from the University of California, Irvine, where I focused on developing innovative Bayesian nonparametric methods with broad applications in fields ranging from imaging to educational data analysis. As a postdoctoral scholar at Stanford University, I have expanded my research portfolio by integrating both frequentist and Bayesian perspectives to address challenges in clinical trial analysis and biomedical data interpretation, incorporating deep learning approaches.
-
Anil K. Panigrahi, MD, PhD, FASA
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor (By courtesy), PathologyBioDr. Anil Panigrahi is a Clinical Associate Professor in the Departments of Anesthesiology and, by courtesy, Pathology at Stanford University School of Medicine. Dual board-certified in Anesthesiology and Blood Banking/Transfusion Medicine, he maintains active clinical practice in both fields. He serves as Chair of the Stanford Health Care Transfusion Committee, Medical Director of the Anesthesiology Perioperative Anemia Management Clinic, and Assistant Medical Director of the Stanford Health Care Transfusion Service. His academic and clinical leadership focuses on advancing perioperative blood management strategies to optimize outcomes in complex surgical patients.
A Phi Beta Kappa graduate of Duke University, Dr. Panigrahi received his M.D. and Ph.D. degrees from the University of Pennsylvania School of Medicine, where he was awarded the John G. Clark Prize for meritorious research. He completed residency training in Anesthesiology and fellowship in Blood Banking/Transfusion Medicine at Stanford University.
Dr. Panigrahi’s scholarly work spans immunology, transfusion safety, and patient blood management. He has authored numerous peer-reviewed publications, textbook chapters, including for Miller’s Anesthesia and the AABB Technical Manual, and national guidelines. He contributes nationally through service on multiple committees for the American Society of Anesthesiologists (ASA) and the Association for the Advancement of Blood and Biotherapies (AABB), and he is a frequent invited speaker at national and international meetings, including those of the ASA, AABB, and Society for the Advancement of Patient Blood Management (SABM). -
Susan Julia Parson
Clinical Assistant Professor (Affiliated), Pathology Clinical
Staff, Pathology Operations supported expensesBioAssistant Medical Examiner-Coroner / Forensic Pathologist
Santa Clara County Office of the Medical Examiner-Coroner
850 Thornton Way San Jose, CA 95128
(408) 793-1900
https://mec.santaclaracounty.gov/home -
Deanna Pepin
Postdoctoral Scholar, Pathology
BioHey there! I was born in the small town of Selkirk, Manitoba, but lived most of my life in Edmonton, Alberta. I completed my Bachelor of Science at Kings University, focusing on biology and did undergrad research on Pink Pigmented Facultative Methylotrophs - bacteria that degrade petrochemicals. Following graduation, I became a Research Technician with Exciton Technologies Inc., a research and development company producing silver-based wound care products for treating infections. In 2016, I joined Dr. Benjamin Willing’s lab in Agriculture, Food, and Nutritional Sciences at the University of Alberta and completed a Master of Science focusing on how certain husbandry changes impact the development of the gastrointestinal microbiota, Salmonella infection resistance, and immune response in broiler production. In 2024, I completed my PhD in the department of Microbiology & Immunology at UBC, working with Dr. Carolina Tropini to understand the impact of osmotic stress on the gut microbiome.
-
Amalia Perna
Postdoctoral Scholar, Pathology
BioDr. Perna received her education at the University of Urbino (BSc in Biological Science) and at the University of Trieste (MSc in Functional Genomics).
She obtained her Ph.D. in Neuroscience/Medical Sciences in 2021, from the University of Fribourg (Switzerland) in collaboration with the Swiss Integrative Center for Human Health (SICHH). During her doctoral studies, she investigated the molecular players involved in the neurodegenerative process, with special attention to Notch signaling modulation in the neuronal demise after kainic acid (KA)-induced excitotoxicity
With funding from the Swiss National Science Foundation (SNSF), Dr. Perna joined Prof. Thomas Montine's lab at Stanford University and extended her doctoral research work to single-cell technologies such as single-nucleus RNA-seq. In February 2022 she was appointed as a postdoctoral fellow in Montine Lab.
Dr. Perna’s research aims to elucidate the modulation of signaling pathways in the different cell types of the brain after the perturbation of its homeostasis. She is also interested in understanding the molecular mechanisms underlying neuronal regeneration/recovery after damage and in neurodegenerative diseases. -
Tho Duc Pham
Clinical Professor, Pathology
Current Research and Scholarly InterestsMy areas of interest involve exploring antibody function as it relates to transfusion medicine, blood safety, and emerging infectious diseases. This ranges from natural immune responses to the ABO blood group, antibody profiling anti-SARS-CoV-2 antibodies, and studying HEV seroprevalence in the local community. I am also interested in exploring statistical approaches to improve blood product availability and overall health care efficiency in a tertiary care system.
-
Benjamin Pinsky
Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)
Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.
-
Jonathan Pollack
Professor of Pathology
Current Research and Scholarly InterestsResearch in the Pollack lab centers on translational genomics, with a focus on prostate diseases. The lab employs next-generation sequencing, single-cell and spatial genomics, gene editing, and human cell/tissue-based modeling to uncover disease mechanisms, biomarkers and therapeutic targets. Current areas of emphasis include benign prostatic hyperplasia, prostate cancer, and rare/neglected cancer types (ameloblastoma, liposarcoma).
-
Chenhui Qiu
Postdoctoral Scholar, Pathology
BioChenhui Qiu majored in Biomedical Engineering and received Ph.D at Zhejiang University.
Then, he was a postdoc and research associate at Department of Applied Mathematics, School of Mathematical Sciences, Zhejiang University.
Then, he was a postdoc at Department of Radiation Oncology, School of Medicine, Stanford University.
Currently, he is a postdoc at Department of Pathology, School of Medicine, Stanford University.
His research interests are medical image analysis, tumor detection & diagnosis, radiation therapy, treatment planning (optimization), dose delivery and measurement. -
Mobeen Rahman
Clinical Associate Professor, Pathology
BioI have interest in head and neck oncological surgical pathology. Specifically in salivary gland, thyroid, and skull base related malignancies.
Prior to joining faculty as an assistant professor at Stanford University, I completed a head and neck surgical pathology fellowship at the MD Anderson Cancer Center (2019). Following this subspecialty fellowship, I was faculty as a head and neck only pathologist at Cleveland Clinic for three years. -
Donald Regula, MD
Professor (Teaching) of Pathology, Emeritus
BioDr. Regula was the course director for the required medical student course, Science of Medicine, and previously the course director of the required pathology course (1993-2020)
He was the Director of the Stanford Autopsy Service (1995-2021)
He is the faculty co-lead for the EPIC Beaker-AP implementation project. -
Mara Rendi, MD, PhD
Clinical Professor, Pathology
BioDr. Rendi is a breast and gynecologic pathologist with a focus on the education of medical students, residents, and practicing pathologists. Her areas of interest include the utilization of molecular testing in breast cancer, management of high-risk lesions, ancillary testing to aid in the use of novel therapeutics, and development and delivery of effective pathology education to medical students. She is a nationally and internationally known medical educator having won multiple teaching awards for her innovative strategies in pathology education. She is actively involved in undergraduate medical education, resident education, and continuing medical education for practicing pathologists as well as a practicing breast and gynecologic pathologist.
-
Pema Richeson
Research Program Manager, Pathology - Montine Lab
Current Role at StanfordProgram Manager | Team eDyNAmiC, Cancer Grand Challenges
Project Manager | PPMI Pathology Core -
Kerri E. Rieger, MD, PhD
Clinical Professor, Pathology
Clinical Professor, DermatologyBioDr. Rieger is a Clinical Professor of Pathology and Dermatology at Stanford University. She received her M.D., Ph.D. from Stanford University School of Medicine and completed her Dermatology Residency and Dermatopathology Fellowship at Stanford University. She is board certified in Dermatology and Dermatopathology. She evaluates skin specimens in the Pathology department, where her interests include histopathologic findings in cutaneous lymphoma, hospitalized patients, and patients with autoimmune disease. She also sees patients in the Stanford dermatology clinic in Portola Valley, where her clinical interest is adult general dermatology.
-
Suman Rimal
Postdoctoral Scholar, Pathology
BioResearch interests: Genetic mechanism underlying mitochondrial pathology, neurodegeneration, and muscle loss using Drosophila as a model organism.
-
Theodore Roth
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Roth Lab develops, applies, and translates scalable genetic manipulation technologies in primary human cells and complex in vivo tissue environments. Working with students, trainees, and staff with backgrounds across bioengineering, genetics, immunology, oncology, and pathology, the lab has developed CRISPR-All, a unified genetic perturbation language able to arbitrarily and combinatorially examine genetic perturbations across perturbation type and scale in primary human cells. Ongoing applications of CRISPR-All in the lab have revealed surprising capacities to synthetically engineer human cells beyond evolved cellular states. These new capacities to perturb human cell’s genetics beyond their evolved functionality drives ongoing work to understand the biology and therapeutic potential of synthetic cell state engineering - in essence learning how to build new human genes tailor made for a specific cell and specific environment to drive previously inaccessible therapeutic cellular functions.
-
Atif Saleem
Clinical Assistant Professor (Affiliated), Pathology Clinical
Staff, Pathology Operations supported expensesBioDr. Atif Saleem completed his residency training in Anatomic and Clinical Pathology, followed by fellowships in Hematopathology and Dermatopathology at Stanford. He is board certified in both Anatomic Pathology and Clinical Pathology, Hematopathology, and Dermatopathology. His interests include virus-associated neoplasms, medical education, and global health.
-
Darren Salmi
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsCardiovascular pathology, congenital heart disease, autopsy, medical education
-
Matteo Santoro Pharm.D., Ph.D.
Postdoctoral Scholar, Pathology
BioDr. Santoro joined Shamloo’s lab in March 2021 focusing his research on Parkinson’s disease, neuronal vulnerability, and identification of therapeutic markers in relation to α-synucleinopathies. Prior to his arrival at Stanford, he held a position as a clinical monitor at Syneos Health where he gained key knowledge needed to translate lab-based findings into clinical and commercial applications. Previously, Dr. Santoro held a postdoctoral position at the University of Aberdeen (Scotland, UK) working on amyloid-beta extracts from Alzheimer’s disease patients. During his postdoctoral research, Dr. Santoro designed and optimized a cost-effective and rapid assay for the measurement of toxic amyloid-beta species in human biofluids. In 2017, he obtained his Ph.D. (4-year program) at the University of Aberdeen on Parkinson’s disease (PD), immunology, and behavior. The major findings Ph.D. findings were the following: 1) the characterization of a small protein called HMGB1 as an inflammatory mediator in PD; 2) the motor and non-motor behavioral characterization of three neurotoxin based mouse models of PD, 3) the characterization of the innate immune response in PD through the toll-like receptor signaling pathways 4) evaluation of the effects of chronic systemic inflammation on both resident and infiltrating immune cells in the CNS. In 2012 Dr. Santoro attained his Pharm.D. in chemistry and pharmaceutical technology (5-year program) at the University of Calabria (Italy) during which he undertook an internship at the King’s College London (SGDP Centre) and worked for over a year on a rat model of stroke.
-
Ansuman Satpathy
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.
-
Birgitt Schuele
Associate Professor (Research) of Pathology
On Partial Leave from 05/01/2025 To 06/30/2025Current Research and Scholarly InterestsThe Schuele lab focuses on neurogenetics, human stem cell modeling, and gene therapy approaches to uncover disease mechanisms and pathways involved in neurodegeneration in Parkinson's, Alzheimer's disease and related disorders.
